MedPath

Oral Caffeine and Spinal-Induced Hypotension

Not Applicable
Recruiting
Conditions
Spinal Hypotension
Caffeine
Interventions
Registration Number
NCT07076654
Lead Sponsor
Cairo University
Brief Summary

Hypotension after spinal anesthesia is critical. Thus several interventions have been proposed to mitigate such effect.

Detailed Description

Hypotension is a critical issue related to spinal anesthesia during cesarean delivery. Researchers of this study aimed to evaluate the impact of preoperative oral caffeine on the incidence of spinal hypotension during cesarean delivery.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • full term pregnant
  • undergoing elective cesarean delivery
Exclusion Criteria
  • patient refusal
  • baseline systolic pressure < 100 mmHg
  • contraindication to spinal anesthesia
  • allergy to caffeine

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CaffeineCaffeine (200 mg)Patients will receive oral caffeine 200 mg before spinal anesthesia
Control groupPlaceboWill receive placebo before spinal anesthesia
Primary Outcome Measures
NameTimeMethod
Incidence of spinal hypotensionAfter spinal anesthesia till delivery

Decrease systolic blood pressure \< 20% of baseline value

Secondary Outcome Measures
NameTimeMethod
Time to first hypotensive episodeafter induction of spinal anesthesia

time to incidence of hypotension

Incidence of severe hypotensionAfter onset of spinal anesthesia

reduced systolic pressure \< 60% of baseline value

APGAR scoreat 5 minutes after delivery

APGAR score calculation at 5 minutes

Umbilical artery pHAt 5 minutes after delivery

Umbilical artery blood gases

Trial Locations

Locations (1)

Cairo University

🇪🇬

Cairo, Cairo Governorate, Egypt

Cairo University
🇪🇬Cairo, Cairo Governorate, Egypt
cairo university
Contact
01275716942
kasralainirec@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.